Nuclear factor E2 p45-related factor 2 negatively regulates chondrogenesis.

[1]  E. Hinoi,et al.  Nrf2 Negatively Regulates Osteoblast Differentiation via Interfering with Runx2-dependent Transcriptional Activation* , 2006, Journal of Biological Chemistry.

[2]  E. Hinoi,et al.  Abolition of chondral mineralization by group III metabotropic glutamate receptors expressed in rodent cartilage , 2005, British journal of pharmacology.

[3]  N. Lee,et al.  Divergent responses of chondrocytes and endothelial cells to shear stress: cross-talk among COX-2, the phase 2 response, and apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Karsenty,et al.  Cooperative Interactions between Activating Transcription Factor 4 and Runx2/Cbfa1 Stimulate Osteoblast-specific Osteocalcin Gene Expression* , 2005, Journal of Biological Chemistry.

[5]  E. Hinoi,et al.  Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage. , 2005, Biochemical pharmacology.

[6]  Y. Surh,et al.  Nrf2 as a novel molecular target for chemoprevention. , 2005, Cancer letters.

[7]  Masayuki Yamamoto,et al.  Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.

[8]  S. Goff,et al.  Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta. , 2004, Genes & development.

[9]  K. Itoh,et al.  Nrf2 deficiency causes tooth decolourization due to iron transport disorder in enamel organ , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[10]  G. Gordon,et al.  A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. , 2004, Molecular cancer therapeutics.

[11]  Y. Henrotin,et al.  The role of reactive oxygen species in homeostasis and degradation of cartilage. , 2003, Osteoarthritis and cartilage.

[12]  E. Moran,et al.  Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. , 2003, Experimental cell research.

[13]  E. Hinoi,et al.  Modulation of cellular differentiation by N‐methyl‐d‐aspartate receptors in osteoblasts , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  G. Karsenty.  The complexities of skeletal biology , 2003, Nature.

[15]  H. Kronenberg,et al.  Developmental regulation of the growth plate , 2003, Nature.

[16]  K. Kataoka,et al.  Induction of Cellular Antioxidative Stress Genes through Heterodimeric Transcription Factor Nrf2/Small Maf by Antirheumatic Gold(I) Compounds* , 2001, The Journal of Biological Chemistry.

[17]  S. Takeda,et al.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.

[18]  S. Nomura,et al.  Maturational disturbance of chondrocytes in Cbfa1‐deficient mice , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[19]  S. Mundlos,et al.  Regulation of chondrocyte differentiation by Cbfa1 , 1999, Mechanisms of Development.

[20]  W. Horton,et al.  Chondrocyte apoptosis in development, aging and disease. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[21]  Y. Kan,et al.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Lamy,et al.  Production of active oxygen species by isolated human chondrocytes. , 1993, British journal of rheumatology.

[23]  C. Pham,et al.  The NF-kappaB-mediated control of ROS and JNK signaling. , 2006, Histology and histopathology.

[24]  J. Hancock,et al.  Detection of superoxide and NADPH oxidase in porcine articular chondrocytes. , 1997, Free radical biology & medicine.

[25]  M. Baker,et al.  The mechanism of chondrocyte hydrogen peroxide damage. Depletion of intracellular ATP due to suppression of glycolysis caused by oxidation of glyceraldehyde-3-phosphate dehydrogenase. , 1989, The Journal of rheumatology.